TapewireFind a company

person · Reporting owner

Cook Jodi A

Disclosed activity across 1 company

Tapewire entity
39610
SEC CIK
0001791004

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
FENNEC PHARMACEUTICALS INC.FENC · Entity 5601DirectorJune 10, 2026June 10, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

FENNEC PHARMACEUTICALS INC.

Report date June 10, 2026 · Filed June 10, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $8.70 · Expires 2036-06-10Direct160,000 Reported balance After 2026-06-10 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-10 · Grant · Acquired 20,000 · Balance 160,000

F1: On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2: The option is 100% vested on date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2: The option is 100% vested on date of grant.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2026 Filed Jun 10, 2026 21:27 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Options · Derivative 20,000 $8.70 Strike: $8.70 $174,000.00
Disclosure

SEC source: 0001791004-26-000002 · form4-06102026_090632.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Shares · 20,000 shares

Expires 2036-06-10

F1 · security: On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:20 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Options · Derivative 20,000 $7.88 Strike: $7.88 $157,600.00
Disclosure

SEC source: 0001415889-25-015589 · form4-06042025_040611.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Shares · 20,000 shares

Expires 2035-06-03

F1 · security: On June 3, 2025, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
August 15, 2024 Filed Aug 19, 2024 23:01 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Options · Derivative 20,000 $5.58 Strike: $5.58 $111,600.00
Disclosure

SEC source: 0001415889-24-021640 · form4-08192024_110834.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Shares · 20,000 shares

Expires 2034-08-15

F1 · security: On August 15, 2024, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
June 12, 2023 Filed Jun 13, 2023 15:47 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Options · Derivative 20,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001415889-23-009705 · form4-06132023_030634.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Shares · 20,000 shares

Expires 2033-06-12

F1 · security: On June 12, 2023, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 13:22 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $5.59 $0.00
Disclosure

SEC source: 0001104659-22-071686 · tm2218610-2_4seq1.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires 2032-06-14

F1 · security: On June 14, 2022, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on the date of grant.

Read SEC document
June 29, 2021 Filed Jun 30, 2021 19:42 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $7.52 $0.00
Disclosure

SEC source: 0001104659-21-087513 · tm2121155-2_4seq1.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires 2031-06-29

F1 · security: On June 29, 2021, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on the date of grant.

Read SEC document
August 13, 2020 Filed Aug 14, 2020 19:15 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $6.17 $0.00
Disclosure

SEC source: 0001104659-20-095444 · tm2027709d2_4.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires 2030-08-13

F1 · security: On August 13, 2020, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on the date of grant.

Read SEC document
November 13, 2019 Filed Nov 14, 2019 16:05 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $5.40 $0.00
Disclosure

SEC source: 0001104659-19-063937 · tm1922795d2_4.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires 2029-11-13

F1 · security: On November 13, 2019, Jodi Cook was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan. 100% of the shares under this option were fully vested on the date of grant

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.